Manufacturers/Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc.

7 drugs in NADAC|0 Generic,7 Brand

Catalyst Pharmaceuticals, Inc. lists 7 NDCs in the CMS NADAC file (0 generic, 7 brand), at an average NADAC of $31.41 per unit, with a week-over-week move of -0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.

Total Drugs

7

0G / 7B

Avg Price / Unit

$31.4071

$4.46 – $39.17

Avg 7d Change

-0.03%

Across 6 drugs with changes

7d Activity

61 flat

of 7 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Frequently Asked Questions

How many drugs does Catalyst Pharmaceuticals, Inc. make?

Catalyst Pharmaceuticals, Inc. lists 7 NDCs in the CMS NADAC file — 0 generic and 7 brand products.

What is the average price of Catalyst Pharmaceuticals, Inc. drugs?

The average NADAC across Catalyst Pharmaceuticals, Inc.'s portfolio is $31.4071 per unit, ranging from $4.4624 to $39.1742.

What types of drugs does Catalyst Pharmaceuticals, Inc. make?

Catalyst Pharmaceuticals, Inc. makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Noncompetitive AMPA Glutamate Receptor Antagonist (7).

Has Catalyst Pharmaceuticals, Inc. had any drug recalls?

No FDA enforcement recalls are matched to Catalyst Pharmaceuticals, Inc. in the openFDA feed.

How has Catalyst Pharmaceuticals, Inc.'s pricing changed recently?

Over the past 7 days, 0 Catalyst Pharmaceuticals, Inc. products rose and 6 fell, with a portfolio-wide average change of -0.0%.

Drug Portfolio

7 drugs total, 7 shown